CFA
BIIB icon

Clarfeld Financial Advisors’s Biogen BIIB Stock Holding History

Clarfeld Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$16K Buy
+53
New +$16.9K 0.01% 178

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Clarfeld Financial Advisors's BIIB Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Biogen (BIIB) in Q4 2018: 53 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #178 among its holdings.

1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Clarfeld Financial Advisors held 53 shares of Biogen worth $16K as of Q4 2018.
  • Biogen was a new Clarfeld Financial Advisors position in Q4 2018.
  • Biogen made up 0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #178 holding.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.